title: Postmastectomy locoregional recurrence and recurrence-free survival in breast cancer patients.
abstract: BACKGROUND
  One essential outcome after breast cancer treatment is recurrence of the disease. Treatment decision is based on assessment of prognostic factors of breast cancer recurrence. This study was to investigate the prognostic factors for postmastectomy locoregional recurrence (LRR) and survival in those patients.
  
  
  METHODS
  114 patients undergoing mastectomy and adjuvant radiotherapy in Cancer Institute of Tehran University of Medical Sciences were retrospectively reviewed between 1996 and 2008. All cases were followed up after initial treatment of patients with breast cancer via regular visit (annually) for discovering the LRR. Cumulative recurrence free survival (RFS) was determined using the Kaplan-Meier method, with univariate comparisons between groups through the log-rank test. The Cox proportional hazards model was used for multivariate analysis.
  
  
  RESULTS
  The median follow up time was 84 months (range 2-140). Twenty-three (20.2%) patients developed LRR. Cumulative RFS rate at 2.5 years and 5 years were 86% (95%CI, 81-91) and 82.5% (95%CI, 77-87) respectively. Mean RFS was 116.50 +/- 4.43 months (range, 107.82 - 125.12 months, 95%CI). At univariate and multivariate analysis, factors had not any influence on the LRR.
  
  
  CONCLUSIONS
  Despite use of adjuvant therapies during the study, we found a LRR rate after mastectomy of 20.2%. Therefore, for patients with LRR without evidence of distant disease, aggressive multimodality therapy is warranted.
authors.affiliation: Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
authors.forename: Ali Arab
authors.initials: AA
authors.lastname: Kheradmand
authors.forename: Neda
authors.initials: N
authors.lastname: Ranjbarnovin
authors.forename: Zahra
authors.initials: Z
authors.lastname: Khazaeipour
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001943:Breast Neoplasms / Q000401:mortality* / Q000473:pathology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis; D008297:Male; D008408:Mastectomy; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000401:mortality* / Q000473:pathology*; D009367:Neoplasm Staging; D012189:Retrospective Studies; D015996:Survival Rate; D016896:Treatment Outcome
references.citation: BMJ. 1991 Jul 20;303(6795):155-8
references.pmid: 1878638
references.citation: Cancer. 1983 Jun 15;51(12 Suppl):2547-52
references.pmid: 6342752
references.citation: Br J Cancer. 1990 Jun;61(6):873-6
references.pmid: 2164836
references.citation: J Clin Oncol. 1999 Jun;17(6):1689-700
references.pmid: 10561205
references.citation: Eur J Cancer. 1990;26(6):668-70
references.pmid: 2144152
references.citation: Eur J Surg Oncol. 1989 Dec;15(6):476-85
references.pmid: 2557247
references.citation: N Z Med J. 1996 Sep 13;109(1029):330-3
references.pmid: 8862351
references.citation: J Natl Cancer Inst Monogr. 1992;(11):7-13
references.pmid: 1627432
references.citation: J Natl Cancer Inst. 2006 Dec 20;98(24):1767-76
references.pmid: 17179478
references.citation: Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1337-47
references.pmid: 15817335
references.citation: J Clin Oncol. 2000 Aug;18(15):2817-27
references.pmid: 10920129
references.citation: JAMA. 2007 Jul 18;298(3):289-98
references.pmid: 17635889
references.citation: Int J Radiat Oncol Biol Phys. 2006 Aug 1;65(5):1345-52
references.pmid: 16750315
references.citation: Cancer. 2006 Jan 1;106(1):35-41
references.pmid: 16333848
references.citation: Cancer. 2008 Apr 1;112(7):1437-44
references.pmid: 18286526
references.citation: Lancet. 2002 Apr 27;359(9316):1471-7
references.pmid: 11988246
references.citation: World J Surg. 1994 Jan-Feb;18(1):70-5
references.pmid: 8197779
references.citation: CA Cancer J Clin. 2001 Jan-Feb;51(1):15-36
references.pmid: 11577478
references.citation: Ann Oncol. 2007 May;18(5):859-67
references.pmid: 17301074
references.citation: Arch Surg. 1990 Jun;125(6):771-5; discussion 775-7
references.pmid: 2161207
references.citation: J Natl Cancer Inst Monogr. 1992;(11):27-32
references.pmid: 1627428
references.citation: Med J Aust. 2002 Oct 7;177(7):347-51
references.pmid: 12358575
references.citation: J Natl Cancer Inst. 2005 Jan 19;97(2):116-26
references.pmid: 15657341
references.citation: Int J Radiat Oncol Biol Phys. 2002 Mar 15;52(4):980-8
references.pmid: 11958892
references.citation: J Natl Cancer Inst. 1992 May 6;84(9):683-9
references.pmid: 1314910
references.citation: CA Cancer J Clin. 1994 Jan-Feb;44(1):7-26
references.pmid: 8281473
references.citation: Int J Radiat Oncol Biol Phys. 1986 Jun;12(6):873-8
references.pmid: 3721930
references.citation: CA Cancer J Clin. 2005 Jan-Feb;55(1):10-30
references.pmid: 15661684
references.citation: N Engl J Med. 2007 Jun 7;356(23):2399-405
references.pmid: 17554121
references.citation: Ai Zheng. 2009 Apr;28(4):395-401
references.pmid: 19622300
references.citation: Cancer. 1969 Nov;24(5):1071-80
references.pmid: 5353940
references.citation: Br J Cancer. 1957 Sep;11(3):359-77
references.pmid: 13499785
references.citation: N Engl J Med. 1997 Oct 2;337(14):949-55
references.pmid: 9395428
references.citation: Ann Surg Oncol. 2001 Dec;8(10):828-32
references.pmid: 11776498
references.citation: J Clin Oncol. 2004 Nov 1;22(21):4247-54
references.pmid: 15452182
references.citation: Breast Cancer Res Treat. 2009 Sep;117(1):91-8
references.pmid: 19112615
references.citation: J Natl Cancer Inst. 2001 May 16;93(10):754-62
references.pmid: 11353785
references.citation: Radiother Oncol. 2007 Mar;82(3):247-53
references.pmid: 17306393
references.citation: Arch Surg. 1996 Mar;131(3):301-8
references.pmid: 8611096
references.citation: J Clin Oncol. 1996 Oct;14(10):2738-46
references.pmid: 8874335
references.citation: Eur J Cancer. 1994;30A(3):351-4
references.pmid: 8204358